{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:36:49Z","timestamp":1780609009945,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s40618-018-0917-x","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T06:34:42Z","timestamp":1530167682000},"page":"303-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"42","author":[{"given":"M.","family":"Bicer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alarslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. U.","family":"Kocabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Imamoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aksit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Isil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Baloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Aslanipoiur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Calan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"917_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223\u20131236. \n                    https:\/\/doi.org\/10.1056\/NEJMra041536","journal-title":"N Engl J Med"},{"key":"917_CR2","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745\u20132749. \n                    https:\/\/doi.org\/10.1210\/jc.2003-032046","journal-title":"J Clin Endocrinol Metab"},{"key":"917_CR3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544\u2013551. \n                    https:\/\/doi.org\/10.1093\/humrep\/dep399","journal-title":"Hum Reprod"},{"key":"917_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF et al (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 28:777\u2013784. \n                    https:\/\/doi.org\/10.1093\/humrep\/des463","journal-title":"Hum Reprod"},{"key":"917_CR5","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1210\/jc.2003-030334","volume":"88","author":"RC Christian","year":"2003","unstructured":"Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF, Fitzpatrick LA (2003) Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562\u20132568","journal-title":"J Clin Endocrinol Metab"},{"key":"917_CR6","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1210\/jc.2003-032049","volume":"89","author":"F Orio","year":"2004","unstructured":"Orio F, Palomba S, Spinelli L, Cascella T, Tauchmanov\u00e0 L, Zullo F et al (2004) The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 89:3696\u20133701. \n                    https:\/\/doi.org\/10.1210\/jc.2003-032049","journal-title":"J Clin Endocrinol Metab"},{"key":"917_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/geno.1999.5899","volume":"60","author":"D Conklin","year":"1999","unstructured":"Conklin D, Lofton-Day CE, Haldeman BA, Ching A, Whitmore TE, Lok S et al (1999) Identification of INSL5, a New Member of the insulin superfamily. Genomics 60:50\u201356. \n                    https:\/\/doi.org\/10.1006\/geno.1999.5899","journal-title":"Genomics"},{"key":"917_CR8","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1210\/en.2006-0237","volume":"147","author":"SL Dun","year":"2006","unstructured":"Dun SL, Brailoiu E, Wang Y, Brailoiu GC, Liu-Chen L-Y, Yang J et al (2006) Insulin-like peptide 5: expression in the mouse brain and mobilization of calcium. Endocrinology 147:3243\u20133248. \n                    https:\/\/doi.org\/10.1210\/en.2006-0237","journal-title":"Endocrinology"},{"key":"917_CR9","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1210\/en.2012-1161","volume":"153","author":"O Burnicka-Turek","year":"2012","unstructured":"Burnicka-Turek O, Mohamed BA, Shirneshan K, Thanasupawat T, Hombach-Klonisch S, Klonisch T et al (2012) INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility. Endocrinology 153:4655\u20134665. \n                    https:\/\/doi.org\/10.1210\/en.2012-1161","journal-title":"Endocrinology"},{"key":"917_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2013.02.042","volume":"432","author":"H Mashima","year":"2013","unstructured":"Mashima H, Ohno H, Yamada Y, Sakai T, Ohnishi H (2013) INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors. Biochem Biophys Res Commun 432:586\u2013592. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.042","journal-title":"Biochem Biophys Res Commun"},{"key":"917_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.abb.2017.03.001","volume":"619","author":"M-J Hu","year":"2017","unstructured":"Hu M-J, Wei D, Shao X-X, Wang J-H, Liu Y-L, Xu Z-G et al (2017) Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4. Arch Biochem Biophys 619:27\u201334. \n                    https:\/\/doi.org\/10.1016\/j.abb.2017.03.001","journal-title":"Arch Biochem Biophys"},{"key":"917_CR12","doi-asserted-by":"publisher","first-page":"11133","DOI":"10.1073\/pnas.1411413111","volume":"111","author":"J Grosse","year":"2014","unstructured":"Grosse J, Heffron H, Burling K, Akhter Hossain M, Habib AM, Rogers GJ et al (2014) Insulin-like peptide 5 is an orexigenic gastrointestinal hormone. Proc Natl Acad Sci USA 111:11133\u201311138. \n                    https:\/\/doi.org\/10.1073\/pnas.1411413111","journal-title":"Proc Natl Acad Sci USA"},{"key":"917_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/BJ20141113","volume":"466","author":"X Luo","year":"2015","unstructured":"Luo X, Li T, Zhu Y, Dai Y, Zhao J, Guo Z-Y et al (2015) The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo. Biochem J 466:467\u2013473. \n                    https:\/\/doi.org\/10.1042\/BJ20141113","journal-title":"Biochem J"},{"issue":"1","key":"917_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347. \n                    https:\/\/doi.org\/10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"917_CR15","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440\u20131447. \n                    https:\/\/doi.org\/10.1210\/jcem-21-11-1440","journal-title":"J Clin Endocrinol Metab"},{"key":"917_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5001\/omj.2012.112","volume":"27","author":"MK Al Kindi","year":"2012","unstructured":"Al Kindi MK, Al Essry FS, Al Essry FS, Mula-Abed W-AS (2012) Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Med J 27:471\u2013474. \n                    https:\/\/doi.org\/10.5001\/omj.2012.112","journal-title":"Oman Med J"},{"key":"917_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"917_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1259\/bjr.70.829.9059301","volume":"70","author":"PS Sidhu","year":"1997","unstructured":"Sidhu PS, Desai SR (1997) A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol 70:85\u201389. \n                    https:\/\/doi.org\/10.1016\/0929-8266(96)88371-6","journal-title":"Br J Radiol"},{"key":"917_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191. \n                    https:\/\/doi.org\/10.3758\/BF03193146","journal-title":"Behav Res Methods"},{"key":"917_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.diabres.2005.10.017","volume":"72","author":"B Geloneze","year":"2006","unstructured":"Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN (2006) The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 72:219\u2013220. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2005.10.017","journal-title":"Diabetes Res Clin Pract"},{"key":"917_CR21","unstructured":"Spanel-Borowski K, Sch\u00e4fer I, Zimmermann S, Engel W, Adham IM (2001) Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev 58:281\u2013286. https:\/\/doi.org\/10.1002\/1098-2795(200103)58:3<281:AID-MRD6>3.0.CO;2-0"},{"key":"917_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1095\/biolreprod66.4.934","volume":"66","author":"HF Irving-Rodgers","year":"2002","unstructured":"Irving-Rodgers HF, Bathgate RAD, Ivell R, Domagalski R, Rodgers RJ (2002) Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome p450, and 3beta-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol Reprod 66:934\u2013943","journal-title":"Biol Reprod"},{"key":"917_CR23","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1210\/en.2012-2232","volume":"154","author":"L Satchell","year":"2013","unstructured":"Satchell L, Glister C, Bleach EC, Glencross RG, Bicknell AB, Dai Y et al (2013) Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles. Endocrinology 154:1897\u20131906. \n                    https:\/\/doi.org\/10.1210\/en.2012-2232","journal-title":"Endocrinology"},{"key":"917_CR24","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/humrep\/det349","volume":"28","author":"R Anand-Ivell","year":"2013","unstructured":"Anand-Ivell R, Tremellen K, Dai Y, Heng K, Yoshida M, Knight PG et al (2013) Circulating insulin-like factor 3 (INSL3) in healthy and infertile women. Hum Reprod 28:3093\u20133102. \n                    https:\/\/doi.org\/10.1093\/humrep\/det349","journal-title":"Hum Reprod"},{"key":"917_CR25","doi-asserted-by":"publisher","first-page":"E1575","DOI":"10.1210\/jc.2013-1107","volume":"98","author":"C Pelusi","year":"2013","unstructured":"Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R (2013) Parallel variations of insulin-like peptide 3 (INSL3) and antim\u00fcllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. J Clin Endocrinol Metab 98:E1575\u2013E1582. \n                    https:\/\/doi.org\/10.1210\/jc.2013-1107","journal-title":"J Clin Endocrinol Metab"},{"key":"917_CR26","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1210\/jc.2006-1678","volume":"92","author":"A Gambineri","year":"2007","unstructured":"Gambineri A, Patton L, De Iasio R, Palladoro F, Pagotto U, Pasquali R (2007) Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. J Clin Endocrinol Metab 92:2066\u20132073. \n                    https:\/\/doi.org\/10.1210\/jc.2006-1678","journal-title":"J Clin Endocrinol Metab"},{"key":"917_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-0042-109869","volume":"48","author":"IV Wagner","year":"2016","unstructured":"Wagner IV, Flehmig G, Scheuermann K, L\u00f6ffler D, K\u00f6rner A, Kiess W et al (2016) Insulin-like peptide 5 interacts with sex hormones and metabolic parameters in a gender and adiposity dependent manner in humans. Horm Metab Res 48:589\u2013594. \n                    https:\/\/doi.org\/10.1055\/s-0042-109869","journal-title":"Horm Metab Res"},{"key":"917_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molmet.2016.01.007","volume":"5","author":"YS Lee","year":"2016","unstructured":"Lee YS, De Vadder F, Tremaroli V, Wichmann A, Mithieux G, B\u00e4ckhed F (2016) Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production. Mol Metab 5:263\u2013270. \n                    https:\/\/doi.org\/10.1016\/j.molmet.2016.01.007","journal-title":"Mol Metab"},{"key":"917_CR29","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981\u20131030. \n                    https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"917_CR30","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, DA Futterweit W (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165\u20131174","journal-title":"Diabetes"},{"key":"917_CR31","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.ATV.0000024222.06463.21","volume":"22","author":"MJ J\u00e4rvisalo","year":"2002","unstructured":"J\u00e4rvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J et al (2002) Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22:1323\u20131328. \n                    https:\/\/doi.org\/10.1161\/01.ATV.0000024222.06463.21","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"917_CR32","doi-asserted-by":"publisher","first-page":"e000087","DOI":"10.1161\/JAHA.113.000087","volume":"2","author":"JF Polak","year":"2013","unstructured":"Polak JF, Szklo M, Kronmal RA, Burke GL, Shea S, Zavodni AEH et al (2013) The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2:e000087\u2013e000087. \n                    https:\/\/doi.org\/10.1161\/JAHA.113.000087","journal-title":"J Am Heart Assoc"},{"key":"917_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199901073400103","volume":"340","author":"DH O\u2019Leary","year":"1999","unstructured":"O\u2019Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14\u201322. \n                    https:\/\/doi.org\/10.1056\/NEJM199901073400103","journal-title":"N Engl J Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0917-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0917-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0917-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T19:07:31Z","timestamp":1568747251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0917-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0917-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"14 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study adhered strictly to the principles of the Declaration of Helsinki as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The subjects gave their oral and written informed consent before their inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have nothing to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}]}}